InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Goff Brian, EVP et Directeur Commercial. Insider active across 2 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 6 disclosures have been recorded. The latest transaction was disclosed on 21 July 2021 — Disposition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
0150,832 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000069·
0150,832 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000069:0·
030,643 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000051·
030,643 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000051:0·
€157,9101,086 shares@ €145.4055100.0% of flow
Common Stock, par value $.0001 per share
SEC:0000899866-21-000049·
€157,9101,086 shares@ €145.405550.0% of flow
Common Stock, par value $.0001 per share
SEC:0000899866-21-000049:0·
6 of 6 declarations
About Goff Brian
Brian Goff is EVP & Chief Commercial Officer at Alexion Pharmaceuticals, Inc. He is responsible for the company's commercial strategy and business development. His expertise in the pharmaceutical sector is essential for leading growth initiatives.
